Meddo is a healthtech startup based in Gurugram, India, that operates a network of doctor-run clinics and digital consultations for patients.

This Startup Deep Dive explains what Meddo does, how it makes money, who backs it, how it compares with rivals and what could go wrong, using publicly available information. It is educational and not investment advice. Last updated: October 2026.

Meddo in Brief

• What it is: Meddo is an Indian Clinic network healthtech company based in Gurugram.
• Who it serves: patients, doctors, hospitals, diagnostic centres, insurers and employers.
• Meddo operates a network of doctor-run clinics in Delhi NCR, built by bringing independent OPD clinics under the Meddo brand with technology.
• It reported over 350 doctors, 200 clinics and over 6 lakh customers by early 2021 (company-stated).
• Services span doctor consultations, telemedicine, diagnostics with home sample collection, medicine delivery and wellness.
• Funding: $6 million pre-Series A (2019-2021); an aggregator lists $12 million+, so reports differ.

Meddo Quick Facts

Figures marked “reported” come from published reports and may differ between sources; “Not disclosed” means no reliable public figure was found.

What Is Meddo?

Meddo operates in the Clinic network healthtech space in India. Understanding a company like this starts with three questions: who is the customer, what painful problem is being solved, and why the solution is better than the alternatives. The sections below apply that lens to Meddo.

• Meddo operates a network of doctor-run clinics in Delhi NCR, built by bringing independent OPD clinics under the Meddo brand with technology.
• It reported over 350 doctors, 200 clinics and over 6 lakh customers by early 2021 (company-stated).
• Services span doctor consultations, telemedicine, diagnostics with home sample collection, medicine delivery and wellness.
• It launched MeddoSure, an omnichannel unlimited care membership covering online and offline consultations.

The Origin Story of Meddo

Every company starts from a noticed gap and a team willing to commit to closing it. Strong origin stories are specific: a clear problem, a founding team with relevant skills, and an early product that real customers could test. Founder-market fit, meaning the team’s lived experience or technical depth in the domain, tends to predict how fast a young company learns.

• Founders: Saurabh Kochhar, Dr Naveen Nishchal.
• Founded in June 2018 by Saurabh Kochhar, former CEO of Foodpanda, and Dr Naveen Nishchal, co-founder of Cygnus Hospitals.
• The model 'reverse integrates' independent OPD clinics, equipping them with digital tools, diagnostic support and medicine delivery.
• Kochhar holds IIT and IIM degrees; Nishchal is a Harvard graduate.

Key Milestones and Challenges

No startup grows in a straight line. Early years usually involve slow adoption, product rewrites, hiring mistakes and funding gaps. In the Clinic network healthtech sector the common turning points are a first paying customer, a regulatory approval, a successful product demonstration or a funding round that lets the team invest ahead of demand. How a team responds to setbacks says more about resilience than any single headline.

• June 2018: company founded.
• September 2019: $3 million pre-Series A announced, led by SRI Capital (one report dates the start of the round to 2020).
• 2020: revenue grew 2.5x, attributed to telemedicine during the pandemic (company-stated).
• June 2021: pre-Series A closed at $6 million with Picus Capital and Alkemi Capital.
• August 2021: acquired prescription-digitisation company Doxper in a cash and stock deal, aiming for over 1,000 branded clinics in 12-15 months.

Meddo Funding and Investors

Funding history shows how much outside confidence a company has attracted and how long it can operate before needing more capital. Figures below are reported and may differ between sources; valuation figures are estimates unless the company has confirmed them.

• September 2019: $3 million pre-Series A led by SRI Capital with growX Ventures, LetsVenture, Jitendra Gupta and Venture Gurukool.
• Late 2020 to January 2021: extension of about $813K (Rs 5.9 crore), of which SRI Capital $508K and Picus Capital $304K.
• June 2021: round reported closed at $6 million led by SRI Capital, Picus Capital and Alkemi Capital.
• No later round was found.

How Does Meddo Make Money? (Business Model)

A business model describes who pays, how often and how much it costs to serve them. Strong models show repeat usage, improving margins with scale and acquisition channels that do not depend only on paid spend. Weak models show one-off sales, rising costs and growth that stops when spending stops. For companies selling to patients, doctors, hospitals, diagnostic centres, insurers and employers, sales cycles and contract size matter as much as headline growth.

• Revenue from consultations, diagnostics, medicines and membership plans across a network of branded partner clinics.
• Asset-light clinic aggregation: independent doctors keep their clinics while Meddo supplies brand, technology, patient flow and services.
• Doxper's prescription digitisation adds a data and technology layer for doctors.

The Numbers: Meddo Financials

Financial figures show whether growth is turning into a self-sustaining business. Small and private companies often disclose little, so any number below is included only if it was found in public reporting.

• FY22 revenue about Rs 8.8 crore; FY23 revenue about Rs 4.5 crore (down about 49%), expenses Rs 22.7 crore and net loss Rs 18.2 crore (aggregator, unaudited).
• Company-stated: revenue grew 2.5x in 2020.
• Employees about 191 in an aggregator listing.

Market Opportunity for Meddo

Market size is easy to exaggerate, so a useful approach separates the total market from the portion a company can realistically reach with its current product and distribution. The main forces behind demand in this sector are rising chronic disease, growing health insurance penetration, government programmes such as Ayushman Bharat and the Ayushman Bharat Digital Mission, and the shift of care to digital and home settings. Each of these widens the opportunity, but capital efficiency and execution decide who captures it.

• Meddo targets primary care and outpatient care in Delhi NCR, a fragmented market of independent clinics.
• Plans included expansion to other cities and integration with the Bharat Health Stack under the National Digital Health Mission.

Technology and Product at Meddo

Technology is rarely the whole moat, but it drives speed, cost and customer experience. A practical way to assess it is to separate the capability the company controls from the commodity infrastructure it rents. In this sector the important factors are clinical validity, data quality, integration with hospital and lab systems, and trust among doctors and patients.

• Digital patient records, telemedicine and digital consultation tools, plus prescription digitisation through Doxper.

Team and Culture at Meddo

Teams are the most important and least measurable asset of a young company. Look at how complementary the founders’ skills are, how deep the second layer of leadership is, and how the company hires and retains specialists. Culture shows up in small repeated behaviours: how quickly bad news travels upward and whether commitments to customers are kept.

• Saurabh Kochhar (founder and CEO) and Dr Naveen Nishchal (co-founder).
• About 250 trained peri-clinical staff handled in-clinic and at-home sample collection (company-stated, 2021).

Meddo Competitors: Competitive Landscape

A fair competitive analysis names direct rivals, adjacent players who could move into the space, and the customer’s default alternative. Durable advantages include proprietary data or technology, licences and approvals, brand trust, switching costs and cost leadership.

Risks and Challenges for Meddo

• Revenue roughly halved in FY23 while the loss was about four times revenue (aggregator figures).
• No funding or operating updates after 2021-2023 were found.
• Regulatory risk: medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules.
• Clinical and liability risk: errors in care, diagnosis or product quality can damage trust quickly.
• Data privacy risk: health records are sensitive, and breaches or misuse can bring legal and reputational harm.

Risk is not a reason to avoid a company; it is a reason to price it correctly and to monitor the right indicators over time. Regulation in this sector is shaped by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Meddo Growth Outlook: What to Watch

• The 2021 funds were earmarked for expanding clinics in NCR and other cities, technology and MeddoSure.
• Current status is unclear from the sources reviewed.
• Key indicators: patient or user volumes, repeat usage, gross margin, clinical outcomes and cost of acquiring each customer.
• Funding position: Whether Meddo can reach its next milestone before needing new capital.
• Regulation: Changes from the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Industry Context: Where Meddo Fits

India's healthcare market combines a large public system, a fast-growing private hospital sector and an increasingly digital layer. Government initiatives such as Ayushman Bharat and the Ayushman Bharat Digital Mission aim to widen insurance cover and create common digital health records, while telemedicine guidelines and the Digital Personal Data Protection Act shape how digital care and patient data can be used.

Demand is driven by chronic and lifestyle disease, an ageing population, rising insurance penetration and consumers who now expect to book, pay and consult online. Startups in this field compete on trust, clinical quality and convenience, and they must prove outcomes and safety as well as growth.

For readers new to this field, a useful habit is to separate announcements from evidence. A plan, a partnership or a funding headline describes intent, while a delivered product, a paying customer or an audited financial statement describes results. Comparing the two over time shows how reliably a company turns promises into outcomes.

Bull Case and Bear Case for Meddo

An investment thesis is a short, testable statement of why a company could become far more valuable, together with what evidence would prove it wrong. The points below are general to this sector and are not forecasts for Meddo.

Bull case

• Rising insurance cover and digital adoption expand the customer base.
• Strong clinical evidence builds trust with doctors and hospitals.
• Scale can improve unit economics in diagnostics and care delivery.

Bear case

• Regulatory changes can alter permitted products or business models.
• Customer acquisition costs can erode margins.
• A single safety or privacy incident can damage trust.

Lessons Founders and Investors Can Take from Meddo

Studying a company in the Clinic network healthtech space offers lessons that go beyond any single firm. The points below are general lessons for the sector and are not claims about Meddo.

• Trust is the real currency in healthcare, so quality control, clinical evidence and data protection must be built in from the start.
• Distribution through hospitals, clinics, insurers or employers can matter more than a standalone consumer app.
• Unit economics improve when repeat usage replaces expensive one-time customer acquisition.
• Regulatory approvals can take time, so timelines and cash planning should allow for them.
• Integration with existing hospital, lab and records systems reduces friction for adoption.

How to Evaluate Meddo as a Startup

• Customer clarity: Can Meddo name its customer and the problem it solves in one sentence?
• Evidence of demand: Look for repeat customers, signed contracts or measurable usage rather than announcements alone.
• Economics: Check whether margins improve as volume grows.
• Execution: Compare announced timelines with what has actually been delivered.
• Funding runway: Estimate how long current capital lasts at the present spending rate.
• Regulatory standing: Confirm required approvals are in place.
• Customer concentration: Check whether a few customers account for most of the revenue.
• Management depth: Look for experienced leaders beyond the founders and a stable core team.

The Takeaway

Meddo is part of India’s growing Clinic network healthtech ecosystem. The useful lesson from studying it is the discipline of asking structured questions about customers, economics, advantage and resilience. Companies that answer them well, repeatedly and under pressure are the ones that endure. Readers should treat any single report, ranking or funding headline as one input among many, and should re-check key facts against recent company announcements. Because public information on young companies is often limited, patience in verifying claims is part of good analysis. This article is educational and is not investment advice.

• Clear customers and repeat demand matter more than announcements.
• Regulation and capital needs shape how fast a startup in this sector can grow.
• Track a few leading indicators over time rather than one headline metric.

Meddo FAQs: Frequently Asked Questions

What is Meddo?

Meddo is a healthtech startup based in Gurugram, India, that operates a network of doctor-run clinics and digital consultations for patients. It is profiled in the Startup Deep Dive series, which explains business model, funding, competitors and risks.

Who founded Meddo?

Meddo was founded by Saurabh Kochhar, Dr Naveen Nishchal, and the company reports a founding year of 2018.

How much funding has Meddo raised?

$6 million pre-Series A (2019-2021); an aggregator lists $12 million+, so reports differ. Funding figures are reported and may differ between sources, so readers should check the latest company announcements.

How does Meddo make money?

Meddo earns revenue from its Clinic network healthtech products and services sold to patients, doctors, hospitals, diagnostic centres, insurers and employers. The exact revenue mix is described in the business model section and is not fully disclosed publicly.

Who are the competitors of Meddo?

Reported rivals include Practo, Tend, Curai Health, MediBuddy. See the competitor comparison above for how they differ.

What are the main risks for Meddo?

Main risks include medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules, funding and capital needs, competition and regulation by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act. This is educational content, not investment advice.

Related Startup Deep Dives: Primus Senior Living — Primus Senior Living raised a reported $20M seed led by General Catalyst | Suvarna Technosoft — short profile of what is publicly known. Browse the full Startup Deep Dive series.

Source

Source: Publicly available data, published reports, industry research, and other credible sources.